Nausea Medicine Market 2027 by Type, Mode of Administration, Application, Indication | The Insight Partners

Nausea Medicine Market Forecast to 2027 - Covid-19 Impact and Global Analysis - by Type ( Antacids, Antagonists, Anti-Anxiety Drugs, Steroids, Cannabinoids ); Mode of Administration ( IV, Tablets ); Application ( Hospitals, Clinics, Pharmaceutical Companies ); Indication ( Gastroesophageal Reflux Disease (GERD), Viral Gastroenteritis, Motion Sickness And Seasickness, Medication, Chemotherapy )

Report Code: TIPRE00007613 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

Nausea is a state of stomach distress with an urge to vomit. Indication of nausea is motion sickness, medication, and chemotherapy. Ulcer in the stomach can also cause nausea with proper medicine, and dietary plan can treat nausea.

MARKET DYNAMICS

The nausea medicine market is anticipated to grow in the market by the advancement of new technologies. Moreover, with rising demand for these devices is the key application for the growth of the industry. With an increasing number of patients experiencing nausea associated with chemotherapeutic drug use, the segment of chemotherapy-induced nausea is growing at an exceptional rate.

MARKET SCOPE

The "Nausea Medicine Market Analysis to 2027" is a specialized and in-depth study of the pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of in nausea medicine market with detailed market segmentation by type, mode of administration, application, indication and geography. The nausea medicine market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading in nausea medicine market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The nausea medicine market is segmented on the basis of type, mode of administration, application and indication. Based on type the market is segmented as antacids, antagonists, anti-anxiety drugs, steroids and cannabinoids. On the basis of mode of administration IV and tablets. On the basis of application the market is categorized as hospitals, clinics and pharmaceutical companies. On the basis of indication the market is categorized as gastroesophageal reflux disease (GERD), viral gastroenteritis, motion sickness and seasickness, medication and chemotherapy.



Get more information on this report :

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the in nausea medicine market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The nausea medicine market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting nausea medicine market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the nausea medicine market in these regions.



Get more information on this report :

MARKET PLAYERS

The report covers key developments in the in nausea medicine market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from in nausea medicine market are anticipated to have lucrative growth opportunities in the future with the rising demand for in nausea medicine market in the global market. Below mentioned is the list of few companies engaged in the Nausea Medicine market.

The report also includes the profiles of key in nausea medicine market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  ANI Pharmaceuticals, Inc.
  •  AstraZeneca
  •  Cipla Inc.
  •  F. Hoffmann-La Roche Ltd
  •  GlaxoSmithKline plc
  •  Merck & Co., Inc.
  •  Novartis AG
  •  Pfizer Inc.
  •  Sanofi
  •  TESARO, Inc.

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Nausea Medicine Market - By Type
1.3.2 Nausea Medicine Market - By Mode of Administration
1.3.3 Nausea Medicine Market - By Application
1.3.4 Nausea Medicine Market - By Indication
1.3.5 Nausea Medicine Market - By Region
1.3.5.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. NAUSEA MEDICINE MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. NAUSEA MEDICINE MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. NAUSEA MEDICINE MARKET - GLOBAL MARKET ANALYSIS
6.1. NAUSEA MEDICINE - GLOBAL MARKET OVERVIEW
6.2. NAUSEA MEDICINE - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. NAUSEA MEDICINE MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. ANTACIDS
7.3.1. Overview
7.3.2. Antacids Market Forecast and Analysis
7.4. ANTAGONISTS
7.4.1. Overview
7.4.2. Antagonists Market Forecast and Analysis
7.5. ANTI-ANXIETY DRUGS
7.5.1. Overview
7.5.2. Anti-Anxiety Drugs Market Forecast and Analysis
7.6. STEROIDS
7.6.1. Overview
7.6.2. Steroids Market Forecast and Analysis
7.7. CANNABINOIDS
7.7.1. Overview
7.7.2. Cannabinoids Market Forecast and Analysis
8. NAUSEA MEDICINE MARKET - REVENUE AND FORECASTS TO 2027 - MODE OF ADMINISTRATION
8.1. OVERVIEW
8.2. MODE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
8.3. IV
8.3.1. Overview
8.3.2. IV Market Forecast and Analysis
8.4. TABLETS
8.4.1. Overview
8.4.2. Tablets Market Forecast and Analysis
9. NAUSEA MEDICINE MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
9.1. OVERVIEW
9.2. APPLICATION MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS
9.3.1. Overview
9.3.2. Hospitals Market Forecast and Analysis
9.4. CLINICS
9.4.1. Overview
9.4.2. Clinics Market Forecast and Analysis
9.5. PHARMACEUTICAL COMPANIES
9.5.1. Overview
9.5.2. Pharmaceutical Companies Market Forecast and Analysis
10. NAUSEA MEDICINE MARKET - REVENUE AND FORECASTS TO 2027 - INDICATION
10.1. OVERVIEW
10.2. INDICATION MARKET FORECASTS AND ANALYSIS
10.3. GASTROESOPHAGEAL REFLUX DISEASE (GERD)
10.3.1. Overview
10.3.2. Gastroesophageal Reflux Disease (GERD) Market Forecast and Analysis
10.4. VIRAL GASTROENTERITIS
10.4.1. Overview
10.4.2. Viral Gastroenteritis Market Forecast and Analysis
10.5. MOTION SICKNESS AND SEASICKNESS
10.5.1. Overview
10.5.2. Motion Sickness And Seasickness Market Forecast and Analysis
10.6. MEDICATION
10.6.1. Overview
10.6.2. Medication Market Forecast and Analysis
10.7. CHEMOTHERAPY
10.7.1. Overview
10.7.2. Chemotherapy Market Forecast and Analysis
11. NAUSEA MEDICINE MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America Nausea Medicine Market Overview
11.1.2 North America Nausea Medicine Market Forecasts and Analysis
11.1.3 North America Nausea Medicine Market Forecasts and Analysis - By Type
11.1.4 North America Nausea Medicine Market Forecasts and Analysis - By Mode of Administration
11.1.5 North America Nausea Medicine Market Forecasts and Analysis - By Application
11.1.6 North America Nausea Medicine Market Forecasts and Analysis - By Indication
11.1.7 North America Nausea Medicine Market Forecasts and Analysis - By Countries
11.1.7.1 United States Nausea Medicine Market
11.1.7.1.1 United States Nausea Medicine Market by Type
11.1.7.1.2 United States Nausea Medicine Market by Mode of Administration
11.1.7.1.3 United States Nausea Medicine Market by Application
11.1.7.1.4 United States Nausea Medicine Market by Indication
11.1.7.2 Canada Nausea Medicine Market
11.1.7.2.1 Canada Nausea Medicine Market by Type
11.1.7.2.2 Canada Nausea Medicine Market by Mode of Administration
11.1.7.2.3 Canada Nausea Medicine Market by Application
11.1.7.2.4 Canada Nausea Medicine Market by Indication
11.1.7.3 Mexico Nausea Medicine Market
11.1.7.3.1 Mexico Nausea Medicine Market by Type
11.1.7.3.2 Mexico Nausea Medicine Market by Mode of Administration
11.1.7.3.3 Mexico Nausea Medicine Market by Application
11.1.7.3.4 Mexico Nausea Medicine Market by Indication
11.2. EUROPE
11.2.1 Europe Nausea Medicine Market Overview
11.2.2 Europe Nausea Medicine Market Forecasts and Analysis
11.2.3 Europe Nausea Medicine Market Forecasts and Analysis - By Type
11.2.4 Europe Nausea Medicine Market Forecasts and Analysis - By Mode of Administration
11.2.5 Europe Nausea Medicine Market Forecasts and Analysis - By Application
11.2.6 Europe Nausea Medicine Market Forecasts and Analysis - By Indication
11.2.7 Europe Nausea Medicine Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Nausea Medicine Market
11.2.7.1.1 Germany Nausea Medicine Market by Type
11.2.7.1.2 Germany Nausea Medicine Market by Mode of Administration
11.2.7.1.3 Germany Nausea Medicine Market by Application
11.2.7.1.4 Germany Nausea Medicine Market by Indication
11.2.7.2 France Nausea Medicine Market
11.2.7.2.1 France Nausea Medicine Market by Type
11.2.7.2.2 France Nausea Medicine Market by Mode of Administration
11.2.7.2.3 France Nausea Medicine Market by Application
11.2.7.2.4 France Nausea Medicine Market by Indication
11.2.7.3 Italy Nausea Medicine Market
11.2.7.3.1 Italy Nausea Medicine Market by Type
11.2.7.3.2 Italy Nausea Medicine Market by Mode of Administration
11.2.7.3.3 Italy Nausea Medicine Market by Application
11.2.7.3.4 Italy Nausea Medicine Market by Indication
11.2.7.4 Spain Nausea Medicine Market
11.2.7.4.1 Spain Nausea Medicine Market by Type
11.2.7.4.2 Spain Nausea Medicine Market by Mode of Administration
11.2.7.4.3 Spain Nausea Medicine Market by Application
11.2.7.4.4 Spain Nausea Medicine Market by Indication
11.2.7.5 United Kingdom Nausea Medicine Market
11.2.7.5.1 United Kingdom Nausea Medicine Market by Type
11.2.7.5.2 United Kingdom Nausea Medicine Market by Mode of Administration
11.2.7.5.3 United Kingdom Nausea Medicine Market by Application
11.2.7.5.4 United Kingdom Nausea Medicine Market by Indication
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Nausea Medicine Market Overview
11.3.2 Asia-Pacific Nausea Medicine Market Forecasts and Analysis
11.3.3 Asia-Pacific Nausea Medicine Market Forecasts and Analysis - By Type
11.3.4 Asia-Pacific Nausea Medicine Market Forecasts and Analysis - By Mode of Administration
11.3.5 Asia-Pacific Nausea Medicine Market Forecasts and Analysis - By Application
11.3.6 Asia-Pacific Nausea Medicine Market Forecasts and Analysis - By Indication
11.3.7 Asia-Pacific Nausea Medicine Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Nausea Medicine Market
11.3.7.1.1 Australia Nausea Medicine Market by Type
11.3.7.1.2 Australia Nausea Medicine Market by Mode of Administration
11.3.7.1.3 Australia Nausea Medicine Market by Application
11.3.7.1.4 Australia Nausea Medicine Market by Indication
11.3.7.2 China Nausea Medicine Market
11.3.7.2.1 China Nausea Medicine Market by Type
11.3.7.2.2 China Nausea Medicine Market by Mode of Administration
11.3.7.2.3 China Nausea Medicine Market by Application
11.3.7.2.4 China Nausea Medicine Market by Indication
11.3.7.3 India Nausea Medicine Market
11.3.7.3.1 India Nausea Medicine Market by Type
11.3.7.3.2 India Nausea Medicine Market by Mode of Administration
11.3.7.3.3 India Nausea Medicine Market by Application
11.3.7.3.4 India Nausea Medicine Market by Indication
11.3.7.4 Japan Nausea Medicine Market
11.3.7.4.1 Japan Nausea Medicine Market by Type
11.3.7.4.2 Japan Nausea Medicine Market by Mode of Administration
11.3.7.4.3 Japan Nausea Medicine Market by Application
11.3.7.4.4 Japan Nausea Medicine Market by Indication
11.3.7.5 South Korea Nausea Medicine Market
11.3.7.5.1 South Korea Nausea Medicine Market by Type
11.3.7.5.2 South Korea Nausea Medicine Market by Mode of Administration
11.3.7.5.3 South Korea Nausea Medicine Market by Application
11.3.7.5.4 South Korea Nausea Medicine Market by Indication
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Nausea Medicine Market Overview
11.4.2 Middle East and Africa Nausea Medicine Market Forecasts and Analysis
11.4.3 Middle East and Africa Nausea Medicine Market Forecasts and Analysis - By Type
11.4.4 Middle East and Africa Nausea Medicine Market Forecasts and Analysis - By Mode of Administration
11.4.5 Middle East and Africa Nausea Medicine Market Forecasts and Analysis - By Application
11.4.6 Middle East and Africa Nausea Medicine Market Forecasts and Analysis - By Indication
11.4.7 Middle East and Africa Nausea Medicine Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa Nausea Medicine Market
11.4.7.1.1 South Africa Nausea Medicine Market by Type
11.4.7.1.2 South Africa Nausea Medicine Market by Mode of Administration
11.4.7.1.3 South Africa Nausea Medicine Market by Application
11.4.7.1.4 South Africa Nausea Medicine Market by Indication
11.4.7.2 Saudi Arabia Nausea Medicine Market
11.4.7.2.1 Saudi Arabia Nausea Medicine Market by Type
11.4.7.2.2 Saudi Arabia Nausea Medicine Market by Mode of Administration
11.4.7.2.3 Saudi Arabia Nausea Medicine Market by Application
11.4.7.2.4 Saudi Arabia Nausea Medicine Market by Indication
11.4.7.3 U.A.E Nausea Medicine Market
11.4.7.3.1 U.A.E Nausea Medicine Market by Type
11.4.7.3.2 U.A.E Nausea Medicine Market by Mode of Administration
11.4.7.3.3 U.A.E Nausea Medicine Market by Application
11.4.7.3.4 U.A.E Nausea Medicine Market by Indication
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America Nausea Medicine Market Overview
11.5.2 South and Central America Nausea Medicine Market Forecasts and Analysis
11.5.3 South and Central America Nausea Medicine Market Forecasts and Analysis - By Type
11.5.4 South and Central America Nausea Medicine Market Forecasts and Analysis - By Mode of Administration
11.5.5 South and Central America Nausea Medicine Market Forecasts and Analysis - By Application
11.5.6 South and Central America Nausea Medicine Market Forecasts and Analysis - By Indication
11.5.7 South and Central America Nausea Medicine Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil Nausea Medicine Market
11.5.7.1.1 Brazil Nausea Medicine Market by Type
11.5.7.1.2 Brazil Nausea Medicine Market by Mode of Administration
11.5.7.1.3 Brazil Nausea Medicine Market by Application
11.5.7.1.4 Brazil Nausea Medicine Market by Indication
11.5.7.2 Argentina Nausea Medicine Market
11.5.7.2.1 Argentina Nausea Medicine Market by Type
11.5.7.2.2 Argentina Nausea Medicine Market by Mode of Administration
11.5.7.2.3 Argentina Nausea Medicine Market by Application
11.5.7.2.4 Argentina Nausea Medicine Market by Indication
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. NAUSEA MEDICINE MARKET, KEY COMPANY PROFILES
13.1. ANI PHARMACEUTICALS, INC.
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. ASTRAZENECA
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. CIPLA INC.
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. F. HOFFMANN-LA ROCHE LTD
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. GLAXOSMITHKLINE PLC
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. MERCK AND CO., INC.
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. NOVARTIS AG
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. PFIZER INC.
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. SANOFI
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. TESARO, INC.
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies

1. ANI Pharmaceuticals, Inc.
2. AstraZeneca
3. Cipla Inc.
4. F. Hoffmann-La Roche Ltd
5. GlaxoSmithKline plc
6. Merck & Co., Inc.
7. Novartis AG
8. Pfizer Inc.
9. Sanofi
10. TESARO, Inc.
TIPRE00007613
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking